Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 32Active not recruiting 13Not yet recruiting 5Withdrawn 2Available 2Terminated 1Completed 1Approved for marketing 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Neoplasms 10Prostatic Neoplasms 7Lung Neoplasms 6Recurrence 4Multiple Myeloma 4Lymphoma, B-Cell 4Lymphoma 4Colorectal Neoplasms 4Breast Neoplasms 4Urinary Bladder Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Urologic Neoplasms 2Solid Tumor 2Small Cell Lung Carcinoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasm Metastasis 2Melanoma 2Lymphoma, Follicular 2Leukemia, Myeloid, Acute 2Leukemia 2Kidney Neoplasms 2Glioblastoma 2Cholangiocarcinoma 2Vasculitis 1Uterine Cervical Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Non-Muscle Invasive Bladder Neoplasms × 90 days × Clear all
NCT07551544 2026-05-19

ANKTIVA Plus BCG Versus BCG Monotherapy In Participants With BCG-Naïve/BCG-Exposed High-Grade Non-Muscle Invasive Papillary Bladder Cancer

ImmunityBio, Inc.

Phase 3 Withdrawn
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT07313891 2026-03-17

BOOST

Relmada Therapeutics, Inc.

Phase 3 Withdrawn
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡